This e-learning course is a comprehensive, self-paced, online course that follows the content of the WHO operational handbook on tuberculosis. Module 4: Treatment – drug-resistant tuberculosis treatment. The main focus of the e-course is programmatic; clinical aspects are only discussed when relevant to specific topics.

The e-course comprises 11 sections and a final assessment and uses a combination of short video lectures, exercises, quiz questions and additional reading materials.

Course Index:

1. Introduction to the e-learning course
2. Rationale for national TB programmes to implement and scale up treatment of DR-TB
3. Key considerations in DR-TB treatment
4. Treatment regimen for isoniazid-resistant rifampicin-susceptible TB
5. Shorter, all-oral bedaquiline-containing treatment regimen
6. Longer treatment regimens for multidrug-resistant TB (MDR-TB)/ rifampicin-resistant TB (RR-TB)
7. The bedaquiline, pretomanid and linezolid (BPaL) regimen for MDR-TB or RR-TB with additional fluoroquinolone resistance 
8. Adjuncts to MDR-TB treatment
9. Patient support to enable adherence to treatment
10. Programmatic implementation of regimens for MDR-TB and RR-TB 
11. Assessing drug-resistant TB programme implementation effectiveness 
12. Final assessment 

This e-learning course is a comprehensive, self-paced, online course that follows the content of the WHO operational handbook on tuberculosis. Module 3: Diagnosis – rapid diagnostics for tuberculosis detection (2021 update). The main focus of the e-course is programmatic; clinical aspects are only discussed when relevant to specific topics.

The e-course comprises seven sections and a final assessment and uses a combination of short video lectures, exercises, quiz questions and additional reading materials.

Course Index:

1. Introduction to the e-learning course
2. Rationale for delivering diagnostic services
3. Key elements of TB diagnostic services
4. WHO-recommended diagnostic tests
   1. Conventional and initial diagnostic test
   2. Follow-on diagnostics, tests recommended against use, and tests in the pipeline 
5. Considerations for the new implementation of new diagnostics
6. Diagnostic algorithms
7. Monitoring the performance of a TB laboratory network
8. Final assessment